Xechem International, Inc. (OTCBB: XKEM) - hit 1,445 trades at close yesterday. Traded up 0.34%.
June 6 - Xechem sickle-cell treatment gets orphan status
Xechem International, Inc. (XKEM.OB) said on Tuesday it had received orphan drug status from the U.S. Food and Drug Administration for a compound known as 5-HMF for treating patients suffering from sickle cell disease.
Orphan drug status entitles a company to various incentives, including seven years of marketing exclusivity for a designated treatment once the FDA approves it.
Playing stocks is like crossing 16 lanes of heavy traffic during rush hour, if you're not extremely careful you are bound to be road pizza.